Kidney Transplant Rejection research hub
8 indexed studies · 4 currently recruiting
- active not recruitingPHASE1, PHASE2
Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients
This study looks at a new treatment called TX200-TR101 for people getting a kidney transplant from a living donor. It aims to help the body accept the new kidney and prevent it from being rejected. Researchers want to check if it's safe and how well it works.
Belgium · Netherlands · United Kingdom - recruiting
Cardio-Renal Registry
This study is looking at patients with kidney disease heart problems. It aims to understand why heart issues are common in people with kidney conditions and how best to treat them. We hope to improve care for these patients.
United Kingdom - recruitingPHASE3
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
This study looks at a new dialysis fluid called XyloCore for people with serious kidney disease. It compares XyloCore to standard fluids to see if it's safe and works well over six months, helping people on home dialysis.
Denmark · Germany · Italy - active not recruitingNA
Xeltis Hemodialysis Access Graft: aXess Pivotal Study
This study is looking at a new type of graft, called the Xeltis aXess graft, for people with kidney failure needing dialysis. It aims to see if it's safe and works well for creating a connection that doctors can use for dialysis treatments.
Belgium · Germany · Greece - recruiting
Association of Middle Molecules Clearance With HDF Volume
This study looks at a special type of dialysis called HDF. We want to understand if a higher volume of fluid used in HDF helps remove more 'middle molecules' from the blood, which could explain why some patients live longer.
United Kingdom - active not recruiting
Continuous Glucose Monitoring in People With Diabetes on Dialysis
This study looks at how blood sugar levels change in people with diabetes who are on dialysis, using a device called a continuous glucose monitor (CGM). It aims to see if these changes are linked to dialysis itself or to long-term health problems like hospital stays.
United Kingdom - recruitingPHASE2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
This study is testing a new medicine, DCR-PHXC, for people with a rare kidney disease called Primary Hyperoxaluria Type 1 (PH1) who also have severe kidney problems. It aims to see how safe and effective the medicine is.
United States · France · Germany - active not recruiting
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
This study is checking on people who had a special treatment (TX200-TR101) for kidney transplant rejection up to 15 years ago. Researchers want to see how everyone is doing long-term to make sure the treatment is safe and well-tolerated.
Belgium · Netherlands · United Kingdom